Wright E, Reddock M, Roberts E, Legesse Y, Perry G, Bradley R
PeerJ. 2024; 12:e17552.
PMID: 38948234
PMC: 11214740.
DOI: 10.7717/peerj.17552.
Jani V, Sonavane U, Joshi R
RSC Adv. 2022; 9(25):14567-14579.
PMID: 35519320
PMC: 9064127.
DOI: 10.1039/c9ra01507h.
Brunori M
Protein Sci. 2021; 30(9):1776-1792.
PMID: 34118168
PMC: 8376413.
DOI: 10.1002/pro.4145.
Restelli E, Capone V, Pozzoli M, Ortolan D, Quaglio E, Corbelli A
J Biol Chem. 2021; 296:100490.
PMID: 33662396
PMC: 8059059.
DOI: 10.1016/j.jbc.2021.100490.
Scollo F, La Rosa C
Life (Basel). 2020; 10(8).
PMID: 32784399
PMC: 7459996.
DOI: 10.3390/life10080144.
Genetic human prion disease modelled in PrP transgenic .
Thackray A, Cardova A, Wolf H, Pradl L, Vorberg I, Jackson W
Biochem J. 2017; 474(19):3253-3267.
PMID: 28814578
PMC: 5606059.
DOI: 10.1042/BCJ20170462.
Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations.
Llorens F, Zarranz J, Fischer A, Zerr I, Ferrer I
Curr Neurol Neurosci Rep. 2017; 17(4):30.
PMID: 28324299
DOI: 10.1007/s11910-017-0743-0.
Toward the Atomic Structure of PrP.
Rodriguez J, Jiang L, Eisenberg D
Cold Spring Harb Perspect Biol. 2017; 9(9).
PMID: 28096267
PMC: 5585850.
DOI: 10.1101/cshperspect.a031336.
The roles of the conserved tyrosine in the β2-α2 loop of the prion protein.
Huang D, Caflisch A
Prion. 2015; 9(6):412-9.
PMID: 26689486
PMC: 4964861.
DOI: 10.1080/19336896.2015.1115944.
Transgenic fatal familial insomnia mice indicate prion infectivity-independent mechanisms of pathogenesis and phenotypic expression of disease.
Bouybayoune I, Mantovani S, Del Gallo F, Bertani I, Restelli E, Comerio L
PLoS Pathog. 2015; 11(4):e1004796.
PMID: 25880443
PMC: 4400166.
DOI: 10.1371/journal.ppat.1004796.
The standard scrapie cell assay: development, utility and prospects.
van der Merwe J, Aiken J, Westaway D, McKenzie D
Viruses. 2015; 7(1):180-98.
PMID: 25602372
PMC: 4306833.
DOI: 10.3390/v7010180.
Creutzfeldt-Jakob disease associated with a V203I homozygous mutation in the prion protein gene.
Komatsu J, Sakai K, Hamaguchi T, Sugiyama Y, Iwasa K, Yamada M
Prion. 2014; 8(5):336-8.
PMID: 25495585
PMC: 4601383.
DOI: 10.4161/19336896.2014.971569.
Negative purifying selection drives prion and doppel protein evolution.
Tsangaras K, Kolokotronis S, Ulrich R, Morand S, Michaux J, Greenwood A
J Mol Evol. 2014; 79(1-2):12-20.
PMID: 25038839
DOI: 10.1007/s00239-014-9632-1.
Evolutionary implications of metal binding features in different species' prion protein: an inorganic point of view.
La Mendola D, Rizzarelli E
Biomolecules. 2014; 4(2):546-65.
PMID: 24970230
PMC: 4101497.
DOI: 10.3390/biom4020546.
Structural and dynamic properties of the human prion protein.
Chen W, van der Kamp M, Daggett V
Biophys J. 2014; 106(5):1152-63.
PMID: 24606939
PMC: 4026773.
DOI: 10.1016/j.bpj.2013.12.053.
Structural diversity and initial oligomerization of PrP106-126 studied by replica-exchange and conventional molecular dynamics simulations.
Ning L, Guo J, Bai Q, Jin N, Liu H, Yao X
PLoS One. 2014; 9(2):e87266.
PMID: 24586266
PMC: 3929351.
DOI: 10.1371/journal.pone.0087266.
The role of Cys179-Cys214 disulfide bond in the stability and folding of prion protein: insights from molecular dynamics simulations.
Ning L, Guo J, Jin N, Liu H, Yao X
J Mol Model. 2014; 20(2):2106.
PMID: 24515720
DOI: 10.1007/s00894-014-2106-y.
Different misfolding mechanisms converge on common conformational changes: human prion protein pathogenic mutants Y218N and E196K.
Cheng C, Daggett V
Prion. 2014; 8(1):125-35.
PMID: 24509603
PMC: 7030917.
DOI: 10.4161/pri.27807.
Thermodynamic characterization of the unfolding of the prion protein.
Moulick R, Udgaonkar J
Biophys J. 2014; 106(2):410-20.
PMID: 24461016
PMC: 3907226.
DOI: 10.1016/j.bpj.2013.11.4491.
Prion protein misfolding, strains, and neurotoxicity: an update from studies on Mammalian prions.
Poggiolini I, Saverioni D, Parchi P
Int J Cell Biol. 2014; 2013:910314.
PMID: 24454379
PMC: 3884631.
DOI: 10.1155/2013/910314.